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OBJECTIVE: Subcutaneous (SC) adipose tissue stearic acid (18:0) content and stearoyl-CoA desaturase-1 (SCD1)-mediated
production of oleic acid (18:1) have been suggested to be altered in obesity. The objective of our study was to examine
abdominal adipose tissue fatty acid content and SCD1 mRNA/protein level in women.
SUBJECTS AND METHODS: Fatty acid content was determined by capillary gas chromatography in SC and omental (OM) fat
tissues from two subgroups of 10 women with either small or large OM adipocytes. Samples from 10 additional women were
used to measure SCD1 mRNA and protein expression, total extracellular signal-regulated kinase 1/2 (ERK1/2) and
phosphorylated ERK1/2 protein as well as insulin receptor (IR) expression levels.
RESULTS: OM fat 18:0 content was signiﬁcantly lower in women with large OM adipocytes compared with women who had
similar adiposity, but small OM adipocytes (2.37±0.45 vs 2.75±0.30mg per 100g adipose tissue, respectively, Pp0.05). OM fat
18:0 content was negatively related to the visceral adipose tissue area (r¼ 0.44, P¼0.05) and serum triglyceride levels
(r¼ 0.56, Po0.05), while SC fat 18:0 content was negatively correlated with total body fat mass (BFM) (r¼ 0.48, Po0.05) and
fasting insulin concentration (r¼ 0.73, Po0.005). SC adipose tissue desaturation index (18:1/18:0), SCD1 expression and
protein levels were positively correlated with BFM. Moreover, obese women were characterized by a reduced OM/SC ratio of
SCD1 mRNA and protein levels. A similar pattern was observed for ERK1/2 and IR expression.
CONCLUSION: The presence of large adipocytes and increased adipose mass in a given fat compartment is related to reduced
18:0 content and increased desaturation index in women, independently of dietary fat intake. The depot-speciﬁc difference
in ERK1/2 expression and activation, as well as in SCD1 and IR expression in obese women is consistent with the hypothesis
that they may predominantly develop SC fat, which could in turn help protect from metabolic disorders.
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INTRODUCTION
In both men and women, excess accumulation of adipose tissue
and hypertrophic adipocytes on anatomical structures such as the
mesentery and greater omentum, also termed intra-abdominal or
visceral obesity, has emerged as a critical determinant of obesity-
related metabolic disorders eventually leading to insulin resis-
tance, type 2 diabetes and cardiovascular disease.
1,2 Speciﬁc
features of each adipose tissue compartment may help explain the
preferential association of visceral fat with cardiometabolic risk
markers, including adipocyte metabolism, adipokine secretion
and tissue expandability.
1 However, a relatively small number of
studies focused on fatty acid content.
3,4
Adipose tissue fatty acid composition is thought to reﬂect
dietary fatty acid intake over a relatively long period. On the basis
of the half-life of adipose tissue fatty acids, a temporal relationship
of approximately 1--3 years has been proposed.
5- -7 Correlations
were reported between dietary polyunsaturated fatty acids intake
and their content in subcutaneous (SC) adipose tissue.
4,8- -13
However, discrepancies have been noted for the association
between dietary intake and the fat tissue content of saturated
fatty acids (SFA), in particular for 14:0, palmitate (16:0) or stearate
(18:0) and monounsaturated fatty acids (MUFA).
4,5
Regarding regional differences, fatty acid composition of
femoral, abdominal and upper arm fat appears to be similar.
5
A few studies reported small (2--10%) but signiﬁcant differences in
the proportions of SFA and MUFA between those sites.
5,14
Furthermore, studies comparing SC and visceral adipose tissue
have demonstrated a higher proportion of MUFA in the former
compared with the latter, and the increase in MUFA occurred at
the expense of SFA content, suggesting a desaturation process.
However, available information is incomplete as most studies
examined SC adipose tissue obtained from only one site
irrespective of other compartments.
5
18:0 is one of the most abundant dietary SFA in the western
diet.
15,16 This fatty acid can also be synthesized by the elongation of
16:0.
16 The 18:0 content of adipose tissue and the 18:0/16:0 ratio
(elongation index) were recently shown to be inversely correlated
with body mass index (BMI) and SC adipocyte cell size in humans,
4
although this ﬁnding is not unanimous.
17 A positive relationship
between adipose tissue 18:0 content and insulin sensitivity
measured by the homeostatic model assessment of insulin
sensitivity was also reported.
4 Although the 18:0 fatty acid has
multiple fates such as elongation, oxidation or esteriﬁcation, it is the
major substrate for stearoyl-CoA desaturase-1 (SCD1).
15
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www.nature.com/nutdSCD1 catalyzes the insertion of a double bond between carbons
9 and 10 of 16:0 and 18:0 converting them to palmitoleate and
oleate, respectively.
15 A recent study in human adipocytes showed
that upregulation of de novo lipogenesis was accompanied by
increased elongation and desaturation, which channels newly
synthesized SFA to oleic acid.
18 Studies in SCD1-null mice showed
that animals are lean and protected from diet-induced obesity as
well as insulin resistance.
15 In humans, Roberts et al.
4 showed that
subjects with a lower 18:1/18:0 ratio (desaturation index) had a
lower BMI and reduced SC adipocyte cell size.
Adipocyte differentiation is orchestrated by numerous transcription
factors such as CCAAT-enhancer-binding protein (C/EBP) family
members and SREBP-1c (sterol regulatory element-binding protein-
1c).
19,20 Mitogen-activated protein kinase (MAPK) and ERK1/2
constitute key factors in this process. ERK1-null mice have reduced
a d i p o s et i s s u em a s sa n da d i p o c y t en u m b e r .
21 The MAPK ERK1/2
pathway was shown to be involved in the activation of the C/EBP
family members
22,23 and represents an early component of adipo-
genesis.
22,23 Hence, high ERK1/2 phosphorylation rates in adipose
tissue may reﬂect a high potential of this tissue to initiate adipocyte
differentiation. Activation of the adipogenic program coordinates the
expression of lipogenic genes, including Scd1, to initiate and maintain
adipocyte functions such as glucose uptake, lipid synthesis and
storage.
20 Recent studies have shown that SCD1 knockdown impairs
insulin-stimulated glucose uptake in human adipocytes.
18
Despite the prevalent idea that fatty acid composition of
adipose tissue reﬂects dietary fat intake, no clear answer has been
provided on regional differences in 18:0 content and how it relates
to obesity or visceral obesity. The present study was designed to
examine the fatty acid content of SC and omental (OM) adipose
tissue in women. We tested the hypothesis that adipose tissue
18:0 content would be reduced in expanded fat compartments
with large adipocytes. This would occur with an increase of the
desaturation index and SCD1 expression.
SUBJECTS AND METHODS
Women of this study were recruited through the elective surgery schedule
of the Gynaecology Unit of the Laval University Medical Center. The study
was approved by the Medical Ethics Committees of Laval University
Medical Center. All subjects provided written informed consent before
their inclusion in the study. We selected a subsample of 20 women to be
included in two subgroups of 10 women with either small (n¼10) or large
(n¼10) OM adipocytes, but individually matched for age, total body fat
mass (BFM) and SC adipocyte size. Women of the study elected for total
abdominal hysterectomies, some with bilateral salpingo ovariectomy
(n¼9). Reasons for surgery included one or more of the following:
myoma/ﬁbroids (n¼14), menorrhagia/menometrorrhagia (n¼9), benign
cyst (n¼6), incapacitating dysmenorrhea (n¼4), endometriosis (n¼4),
chronic pelvic pain (n¼3), endometrial polyp (n¼2), incapacitating
premenstrual syndrome (n¼1), hydatid of Morgani (n¼1) or corpus
luteum (n¼1). SCD1 mRNA expression as well as SCD1 and ERK1/2 protein
levels were measured in an additional subsample of 10 women. These
women were aged 40.1--58.9 years (mean age 48.70±5.96 years), had an
average BMI of 27.6±6.1kgm
 2 (range 19.3- -36.6kgm
 2). They also
elected for total abdominal hysterectomies, some with bilateral salpingo
ovariectomy (n¼9). Reasons for surgery included myoma/ﬁbroids (n¼7),
menorrhagia/menometrorrhagia (n¼5), ovarian cyst (n¼1), endometriosis
(n¼1) and endometrial polyp (n¼1).
Dietary data
Dietary intakes were assessed using a validated food frequency
questionnaire
24 containing 91 food items available in the Quebec City
area and reﬂecting Canadian eating habits. The participants were
questioned about the amount and frequency of intake of items among
the following food groups: vegetables; fruits; legumes; nuts and seeds;
cereals and grain products; milk and dairy products; meat/processed meat;
poultry; ﬁsh; eggs; sweets; oil and fats; fast foods and drinks.
Body fatness and body fat-distribution measurements
Dual-energy X-ray absorptionmetry was used to measure total BFM and
lean body mass. We used a Hologic QDR-2000 densitometer and the
enhanced array whole-body software V5.73A (Hologic, Bedford, MA, USA).
Computed tomography was used to measure the SC and visceral adipose
tissue cross-sectional areas using a GE Light Speed 1.1 CT scanner (General
Electric Medical Systems, Milwaukee, WI, USA) as described.
25
Plasma lipid--lipoprotein measurements
After 12h of fasting on the morning of the surgery, blood samples were
obtained. A Technicon RA-analyzer (Bayer, Etobicoke, ON, Canada) and
enzymatic methods were used to measure cholesterol and triglyceride
levels in plasma. Plasma very low-density lipoproteins were isolated by
ultracentrifugation, and the high-density lipoprotein fraction was obtained
by precipitation of the low-density lipoproteins from the infranatant with
heparin and MnCl2.
26 The cholesterol content of the infranatant was
measured before and after precipitation, and low-density lipoprotein
cholesterol concentration was calculated by difference.
Adipose tissue sampling
SC and OM adipose tissue samples were collected at the site of the surgical
incision (lower abdomen) and at the distal portion of the greater
omentum, respectively, and immediately carried to the laboratory.
Adipocyte isolation was performed by collagenase digestion of a portion
of the fresh adipose tissue sample. Average cell population diameters were
measured by image analysis.
27 Remaining tissue was frozen in liquid
nitrogen and stored at  801C for subsequent analyses.
Fatty acid proﬁle
Adipose tissue total lipids were extracted, fatty acids were methylated and
the fatty acid proﬁle of each sample was determined by capillary gas
chromatography. Fatty acids were identiﬁed according to their retention
time in the column, using a standard mixture of 43 fatty acids as a basis for
comparison (FAME 37 mix, Supelco, Bellefonte, PA, USA), the C15:0 fatty
acids, as well as the following fatty acids: C22:5 w6 (Larodan AB, Malmo ¨,
Sweden), C22:5 w3 (Supelco), C22:5 w3 cis-12, and the mixture of 31 fatty
acids GLC-411 (NuChek Prep, Elysian, MN, USA), C14:1 trans-9, C16:1 trans-9
and isoforms of C18:1 (cis-6, cis-11, cis-12, cis-13-trans-6, trans-11)
(Supelco). Results were expressed as grams of fatty acids per 100g of
adipose tissue.
28
Messenger RNA expression
Total RNA was isolated from SC and OM adipose tissues, tested for quality
and concentration, and used in cDNA synthesis as described.
29 Real-time
cDNA ampliﬁcation was performed in triplicate using the LightCycler 480
(Roche Diagnostics, Indianapolis, IN, USA) and the SYBR Green I Master
(Applied Biosystems, Hayward, CA, USA) as described.
29 Target gene
ampliﬁcations were normalized using expression levels of the following
housekeeping genes: hypoxanthine guanine phosphoribosyl transferase 1
(HPRT1), ATP synthase O subunit (ATP5O) and glucose-6-phosphate
dehydrogenase (G6PD). Associations observed in the present analyses
were not attributable to housekeeping gene variation. Primer sequences
were (sense/anti-sense):
for SCD1: 50-CTCCACTGCTGGACATGAGA-30/50-AATGAGTGAAGGGGCAC
AAC-30;
for ATPase5o: 50-ATTGAAGGTCGCTATGCCACAG-30/50-AACGACTCCTTG
GGTATTGCTTAA-30;
for HPRT1: 50-AGTTCTGTGGCCATCTGCTTAGTA G-30/50-AAAAAACAATCC
GCCCAAAGG-30;
and for G6PD: 50-GATGTCCCCTGTCCCACCAACTCTG-30/50-GCAGGGCAT
TGAGGTTGGGAG-30.
Western blot analyses
Tissues were homogenized in Tris buffer (pH 7.4) with sucrose, EDTA,
proteases and phosphatase inhibitors. Excess fat was removed by
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90min, and the supernatant was recovered and stored at  801C until
analyzed. Protein concentration was determined using the Bio-Rad protein
assay (Bio-Rad, Mississauga, ON, Canada). A total of 40mg protein were
mixed with 6  Laemmli sample buffer (2% SDS, 2% b-mercaptoethanol,
10% v/v glycerol and 50mgl
 1 bromophenol blue in 0.1M Tris-HCl buffer,
pH 6.8), heated at 1001C for 5min, subjected to SDS-polyacrylamide gel
electrophoresis (PAGE) and then transferred to Immobilon-P membranes
for immunoblotting. The membranes were incubated for 1h in blocking
buffer (1  Tris-buffered saline (TBS), 0.1% Tween-20) containing 5% milk
and then overnight in a buffer containing 5% bovine serum albumin (BSA)
and various antibodies raised against SCD1 (1/5000) (generous gift from
Dr J Ozols, Farmington, CT, USA), phospho-ERK1/2 (Thr-202; Tyr-204)
(1/1000), total ERK1/2 (1/1000), glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) (1/2500) (Cell Signalling Technology, Danvers, MA, USA)
or the anti-insulin receptor (anti-IR a-960) (generous gift of Dr BI Posner,
McGill University, QC, Canada). After three washes in tris-buffered saline
and tween 20, the membranes were incubated at room temperature in
tris-buffered saline and tween 20 with an anti-Rabbit IgG binding to
horseradish peroxidase (1/10000) (Bio-Rad). Signals were revealed using
ECL-plus detection reagent (Roche Diagnostics, Laval, PQ, Canada). The
appropriate bands were quantiﬁed using the phospho-imager system
(Molecular imager FX, Bio-Rad).
30
Statistical analyses
Student’s t-tests were used to compare the characteristics of the subjects,
dietary intakes and adipose tissue fatty acid proﬁle between the two
subgroups of women matched for adiposity, but showing small or large
OM adipocytes. Pearson correlations were performed to quantify the
associations of adipose tissue fatty acids with anthropometric, adiposity or
blood lipid values. Pearson correlations were computed to quantify the
associations between SCD1 mRNA expression or protein level in adipose
tissue and other variables of interest. Statistical analyses were performed
using JMP 7.0 software (SAS Institute, Cary, NC, USA).
RESULTS
Characteristics of the subjects
Characteristics of women with small (n¼10) or large OM
adipocytes (n¼10) are shown in Table 1. By design, the
subgroups had similar total BFM, lean body mass and waist
circumference. However, OM adipocyte size was higher in women
with large OM adipocytes (Po0.0001). Although total adipose
tissue areas were similar for both groups of women, those with
large OM adipocytes had higher visceral adipose tissue area and
triglyceride levels.
Table 2 shows the dietary data of the subjects. Women were
eating on average 2084kcal per day. Women in both groups had a
similar dietary intake in terms of energy, macronutrients and
ﬁbers. Both groups consumed the same amount of 16:0, 16:1, 18:0
and oleic (18:1) fatty acids.
Fatty acid composition of adipose tissues and the diet appear
similar on a relative basis
Figure 1 shows a comparison of fatty acid content in the diet (left
panel) and in SC or OM adipose tissue (right panel). On a relative
basis, adipose tissue fatty acid composition of both the SC and OM
compartment was strikingly similar to dietary fatty acid intakes.
The relative content of the main fatty acids, namely 18:1, 16:0, 18:2
and 18:0, were also similar. Positive associations were found
between 14:0 and 20:1 fatty acid intakes and their content in SC
(r¼0.49, Pp0.03) or OM (r¼0.47, Pp0.04) adipose tissue,
respectively. Positive trends were also observed between 18:2
fatty acid intake and their content in SC and OM adipose tissues
(r¼0.42, P¼0.06; r¼0.40, P¼0.08, respectively). Other dietary
fatty acids were not correlated with their counterparts in the
adipose tissue.
Lower 18:0 content and higher desaturation index is associated
with the presence of large OM adipocytes
Adipose tissue fatty acid composition of the subgroups with small
vs large OM adipocytes is shown in Table 3. Women with large OM
adipocytes had signiﬁcantly lower 18:0 content in OM adipose
tissue. Similarly, women with large OM adipocytes had a lower
Table 1. Characteristics of the subjects
Characteristics Small
omental
adipocytes
(n¼10)
Large
omental
adipocytes
(n¼10)
P
Age (years) 47.3±3.9 47.7±3.3 0.81
Weight (kg) 71.8±12.0 71.0±14.9 0.65
BMI (kgm
 2) 26.4±4.7 27.4±5.2 0.65
Waist circumference (cm) 91.5±11.2 96.0±12.7 0.38
Total body fat mass (kg) 27.3±7.6 26.7±7.8 0.74
Lean body mass (kg) 43.7±6.0 42.1±8.6 0.65
Adipose tissue area (cm
2)
Total 398±121 394±141 0.93
Visceral 61±15 98±50 0.02
Subcutaneous 336±122 312±117 0.63
Lipid proﬁle
Cholesterol (mmoll
 1) 4.55±0.98 5.17±0.87 0.15
HDL-cholesterol (mmoll
 1) 1.50±0.37 1.59±0.27 0.50
LDL-cholesterol (mmoll
 1) 2.58±0.74 2.84±0.67 0.42
Triglycerides (mmoll
 1) 1.05±0.30 1.62±0.61 0.01
Cholesterol/HDL-C ratio 3.14±0.73 3.34±0.80 0.54
Apolipoprotein B (mgdl
 1) 0.84±0.19 0.96±0.21 0.19
Insulin (mUml
 1) 8.43±2.67 12.24±7.28 0.23
Glycemia (mmoll
 1) 5.56±0.64 5.99±0.44 0.09
Abdominal adipocyte diameters (mm)
Omental adipocyte size 74.4±7.6 97.6±10.9 o0.0001
Subcutaneous adipocyte size 98.3±11.7 99.5±12.1 0.83
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein;
LDL, low-density lipoprotein. Data are mean±s.d.
Table 2. Dietary intakes of energy, macronutrients, fatty acids and
ﬁbers in women with small or large omental adipocytes, but similar
total adiposity or subcutaneous adipocyte sizes
Small omental
adipocytes (n¼10)
Large omental
adipocytes (n¼10)
P
Energy (kcal/d) 2084±396 1912±347 0.3
Total protein (g/d) 89.4±15.2 74.6±21.1 0.09
Total CHO (g/d) 246±58 238±55 0.8
Total fat (g/d) 81.8±21.1 73.2±21.2 0.3
Total SFA (g/d) 24.1±7.5 22.1±6.5 0.5
Total MUFA (g/d) 36.2±10.7 32.1±10.8 0.4
Total PUFA (g/d) 15.4±4.4 13.1±5.1 0.3
Total 16:0 (g/d) 13.2±3.4 12.0±3.4 0.4
Total 16:1 (g/d) 1.2±0.3 1.1±0.4 0.7
Total 18:0 (g/d) 5.5±1.8 5.3±1.7 0.6
Total 18:1 (g/d) 34.2±10.4 30.3±10.4 0.4
Total ﬁber (g/d) 23.3±5.9 21.2±9.4 0.6
Soluble ﬁber (g/d) 7.4±1.9 7.1±2.8 0.8
Insoluble ﬁber (g/d) 15.8±4.1 14.1±6.6 0.5
Abbrevations: CHO, carbohydrates; MUFA, monounsaturated fatty acids;
PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids. Data are
mean±s.d.
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in women with larger OM adipocytes.
Table 4 shows the correlation coefﬁcients between measures of
16:0, 18:0, elongation or desaturation, and adiposity or blood lipid
values. Measures of overall adiposity, such as the BMI and total
BFM, were inversely correlated with 18:0 content in SC adipose
tissue. SC adipose tissue area tended to be negatively associated
with 18:0 content in the same depot. Furthermore, SC adipocyte
size was also inversely correlated with the elongation index, again
in SC adipose tissue. BMI and SC adipose tissue area were
positively associated with the desaturation index in the SC
compartment, while a positive trend was observed with total
BFM. When examining visceral adiposity, a higher visceral adipose
tissue area was associated with a lower 18:0 content and a higher
desaturation index in the OM depot. Plasma cholesterol concen-
tration tended to be associated with the 18:0 content of OM
adipose tissue. Furthermore, low-density lipoprotein-cholesterol
levels were found to be inversely correlated with the elongation
index in the SC depot. Triglyceride concentrations were negatively
associated with the 18:0 content and elongation index, and
positively associated with desaturation in OM fat. Finally, fasting
insulin was negatively correlated with the 18:0 content, elongation
and desaturation in SC fat. This correlation was absent in the OM
depot.
Different expression pattern of SCD1, ERK1/2 and IR in OM vs SC
adipose tissue
Signiﬁcant positive associations between SCD1 mRNA and protein
expression levels in SC adipose tissue and BFM were observed
(Figure 2 and data not shown). However, this association was not
observed in OM. Figure 3 shows the OM/SC ratio in normal or
overweight women (BMIo30kgm
 2; n¼5) vs obese women
(BMIX30kgm
 2; n¼4) of SCD1 mRNA (panel A) and protein
(panel B) levels. Panel C represents the OM/SC ratio of total and
phosphorylated ERK1/2 (p-ERK1/2), while panel D presents the
ratio of IR expression. Obese subjects were characterized by a
reduced OM/SC ratio of SCD1 mRNA and protein levels as well as a
lower OM/SC ratio of total ERK1/2 protein level and its
phosphorylated form (p-ERK1/2). Similar results were observed
when examining the ratio of the IR expression.
DISCUSSION
Obesity-related alterations in adipose tissue fatty acid composition
have attracted scientiﬁc interest recently, as 18:0 content has been
speciﬁcally shown to be altered in obesity.
4 The aim of the present
study was to examine the fatty acid content of SC and OM adipose
tissues in women with or without abdominal obesity. We tested
the hypothesis that adipose tissue 18:0 content would be reduced
in expanded fat compartments with large adipocytes and that this
would be observed with concomitant increases of the desatura-
tion index and SCD1 expression. We found that fatty acid content
of each adipose tissue compartment was relatively similar to that
Figure 1. Comparison of dietary fatty acid content (left panel) and SC or OM adipose tissue fatty acid composition (right panel). Only fatty
acids that were detected at a value higher than 0.5g fatty acid per 100g adipose tissue are represented.
Table 3. Subcutaneous and omental adipose tissue fatty acid
composition in women with either small or large omental adipocytes,
but similar total adiposity or subcutaneous adipocyte sizes
Small omental
adipocytes (n¼10)
Large omental
adipocytes (n¼10)
P
SC
Total SFA 15.8±2.5 16.4±2.4 0.6
Total MUFA 35.2±5.4 35.1±2.7 1.0
Total PUFA 10.1±1.5 10.0±2.4 0.9
16:0 11.7±1.9 12.3±1.6 0.4
16:1 2.6±0.7 2.8±0.8 0.5
18:0 2.4±0.4 2.3±0.6 0.8
18:1 29.0±4.1 29.0±2.7 0.9
18:0/16:0 0.21±0.03 0.19±0.03 0.2
18:1/18:0 12.3±1.9 13.0±2.8 0.5
OM
Total SFA 15.4±1.2 15.2±1.7 0.7
Total MUFA 32.9±2.8 33.5±2.9 0.6
Total PUFA 9.6±1.3 9.3±2.2 0.7
16:0 10.8±0.9 11.0±1.3 0.7
16:1 2.8±0.5 3.1±1.3 0.6
18:0 2.7±0.3 2.4±0.4 0.04
18:1 27.1±2.7 27.2±2.4 0.9
18:0/16:0 0.25±0.03 0.22±0.05 0.05
18:1/18:0 9.9±0.7 12.0±0.7 0.05
Abbreviations: MUFA, monounsaturated fatty acids; OM, omental; PUFA,
polyunsaturated fatty acids; SC, subcutaneous; SFA, saturated fatty acids.
Data are mean±s.d. (g per 100g of fatty acids).
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women with visceral obesity and large OM adipocytes, while
overall obesity was related to increased SC desaturation, as well as
SCD1 mRNA and protein levels. Adipose tissue 18:0 content has
previously been studied in relation to obesity, but we are the ﬁrst
to address this question with respect to fat distribution.
Previous studies relating adipose tissue fatty acid composition
and dietary fatty acids are equivocal. General consensus is that
adipose tissue fatty acids reﬂect dietary composition.
5 Accord-
ingly, we found that the relative content of most fatty acids was
similar in the diet and adipose tissue. However, when examining
the correlations between speciﬁc dietary fatty acids and their
content in adipose tissue, results were less consistent. Only dietary
14:0 and 20:1 were signiﬁcantly correlated with their counterparts
in a given compartment. We cannot exclude a type 2 error related
to our sample size. The trend for a positive association that we
found between dietary intake of 18:2 and its content in adipose
tissue is consistent with previous data,
5 showing a correlation
between dietary polyunsaturated fatty acids and their adipose
tissue concentration. On the other hand, we did not ﬁnd
correlations between trans fatty acid consumption and adipose
tissue content. This may be due to the new legislation banning
trans fat in Canadian foods, which could have lead to an
overestimation of trans fat intake with our food frequency
questionnaire. Two studies by Garaulet et al.
10,17 examined
adipose tissue and dietary fatty acid content. In the ﬁrst study,
18:1n-9, 16:0 and 18:2n-6 were the most abundant adipose tissue
fatty acids, matching the results of our study. The same group also
found that SFAs were more abundant and MUFAs less abundant in
visceral adipose tissue. We observed opposite results for SFAs and
a trend for MUFAs. In the second study,
17 a higher 16:1 and 18:1
content in visceral and SC adipose tissue, respectively, was
reported in overweight subjects compared with obese and
morbidly obese patients. We did not reproduce these ﬁndings.
Discrepancies could be related to population differences such as
the degree of obesity, sex or dietary patterns.
We examined two subgroups of 10 women with either small or
large OM adipocytes that were matched for age, total BFM and SC
adipocyte size. No difference was observed in the dietary proﬁle of
these subgroups. Adipose tissue fatty acid composition was also
similar, except for 18:0 content, elongation and desaturation
index, which were, respectively, lower and higher in women with
large OM adipocytes. Results obtained with desaturation (18:1/
18:0) and elongation (18:0/16:0) reﬂected those obtained with 18:0
alone, as 18:1, 16:0 and 16:1 contents were not related to any
measure performed. Studies performed in human adipocytes
suggest that elongation and desaturation processes are coordi-
nately regulated to produce oleate.
18,31 Moreover, the abundance
of SFAs is harmful to normal cell function
32 and higher
desaturation rates, and SCD1 expression was shown to protect
against such lipotoxicity.
33 This could possibly be the role of fatty
acid desaturation and elongation in adipose tissue of women with
Table 4. Pearson correlation coefﬁcients between measures of 16:0, 18:0, elongation index or desaturation index and adiposity or blood lipid proﬁle
measures
16:0g FA per 100g AT 18:0g FA per 100g AT Elongation index (18:0/16:0) Desaturation index (18:1/18:0)
SC OM SC OM SC OM SC OM
BMI  0.04  0.08  0.53**  0.36  0.60**  0.28 0.52** 0.30
Waist circumference 0.03 0.03  0.50*  0.51*  0.64**  0.46* 0.41 0.37
Total body fat mass 0.01  0.12  0.48*  0.24  0.57**  0.16 0.42
w 0.10
SAT area 0.03  0.12  0.42
w  0.31  0.54**  0.23 0.43* 0.19
VAT area  0.10 0.09  0.33  0.44*  0.33  0.42
w 0.27 0.45*
SC adipocyte diameter 0.08 0.13  0.40  0.40  0.56**  0.42
w 0.40 0.28
OM adipocyte diameter 0.21 0.05 0.04  0.33  0.20  0.32 0.06 0.29
Cholesterol 0.24 0.07  0.14  0.43
w  0.40  0.41 0.28 0.32
Triglycerides  0.18 0.08  0.33  0.56**  0.27  0.50* 0.33 0.59**
HDL-Cholesterol 0.20  0.22 0.14  0.22  0.05  0.1  0.02 0.1
LDL-Cholesterol 0.29 0.17  0.14  0.28  0.43*  0.33 0.26 0.17
Cholesterol/HDL ratio  0.04 0.30  0.35  0.21  0.36  0.32 0.28 0.23
Fasting insulin  0.33  0.16  0.73**  0.35  0.56**  0.20 0.61** 0.31
Abbreiations: AT, adipose tissue; BMI, body mass index; FA, fatty acid; HDL, high-density lipoprotein; LDL, low-density lipoprotein; OM, omental;
SAT, subcutaneous adipose tissue; SC, subcutaneous; VAT, visceral adipose tissue. *Pp0.05, **Pp0.01,
wP¼0.06.
Figure 2. Associations between SCD1 mRNA expression or SCD1
protein levels in SC adipose tissue (AT) and total BFM. Messenger
RNA expression normalized according to ATP5O mRNA expression
(similar results were obtained using other housekeeping genes,
see Subjects and Methods); protein levels normalized with GAPDH.
Pearson correlation coefﬁcients are shown.
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appreciable variation of 18:1 content may come from the fact that
oleate is by far the most abundant fatty acid present in adipose
tissue (Figure 1). Recent studies in mice and humans indicate that
the content of 16:0 and 16:1 is associated with insulin
resistance.
34- -36 Subjects in our cohorts were healthy and did
not suffer from pronounced metabolic disorders, including
diabetes. However, the fact that adiposity is related to the
substrate rather than the product of the SCD1 reaction needs to
be further investigated.
The 18:0 content of SC fat has been related to total adiposity.
4
When examining the measures of SC or overall obesity, such as
BMI, fat mass, SC adipose tissue area and SC adipocyte size, we
found an inverse correlation between these measures and 18:0
content in the SC depot. Therefore, variables representing the SC
depot are correlated to the size of that same compartment. This is
not in contradiction with our ﬁndings in the matched design,
where SC differences were not apparent. When examining OM
18:0 content in a matched design so that differences in visceral
adipose tissue are emphasized, lower OM 18:0 content is observed
in women with visceral obesity and large OM adipocytes.
However, when focusing on the SC 18:0 content in relation to
overall obesity, a correlation is also observed between BFM and
18:0 content in SC adipose tissue.
SCD1 is the enzyme that introduces a single double bound
between carbons 9 and 10 of the 18:0 fatty acid, converting it to
oleate.
37 In our study, we found positive correlations between SC
desaturation (18:1/18:0), an indirect measure of SCD1 activity, and
Figure 3. OM/SC ratios of SCD1 mRNA expression (a), SCD1 protein level (b), total ERK1/2 protein level, ERK 1/2 phosphorylation state
(p-ERK 1/2) (c) and IR expression (d) in normal or overweight women (BMIo30kgm
 2) vs obese women (BMIX30kgm
 2). SCD1 mRNA
expression values were normalized with G6PD whereas protein expressions were normalized by GAPDH (b-- d). *Po0.05.
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visceral depot, we found a positive correlation between the
desaturation index and visceral adipose tissue area. In the SC
depot, a positive correlation between the levels of SCD1 mRNA/
protein expression and total BFM (Figure 2) was observed.
A similar correlation was also found with BMI (data not shown).
These results are consistent with a recent study from Garcia-
Serrano et al.
38 showing that the variable mainly associated with
SCD1 protein level in SC adipose tissue was BMI.
The activation of ERK1/2 is an early event of adipocyte
differentiation.
21,39 Consistent with the study of Laviola et al.,
40
we observed higher ERK1/2 expression and phosphorylation in
OM vs SC adipose tissue of non-obese women. In obese patients,
the ratio OM/SC was diminished, which suggests that the capacity
for adipocyte differentiation may be impaired in OM adipose
tissue of obese women. Accordingly, a depot-speciﬁc difference
occurs in obese subjects showing lower SCD1 gene expression in
OM vs SC adipose tissue. Our results are consistent with a recent
study showing higher SCD1 expression in SC compared with OM
fat in obese women. SCD1 expression was also associated with
DGAT2 expression, the rate-limiting enzyme in TG synthesis.
41
SCD1 expression is mainly regulated by SREBP-1c at the
transcriptional level in response to insulin by a PI3-kinase-
dependent signaling pathway.
42,43 A similar depot-speciﬁc differ-
ence in non-diabetic obese subjects was already observed for
SREBP-1c.
44 We and others also observed a depot-speciﬁc
difference regarding the level of IR (Figure 3) as well as the
phosphorylation state of insulin sensitive pathways, such as ERK1/
2 and PI3-kinase (Figure 3).
40,45 Indeed, in obese subjects, insulin
was shown to have a more pronounced effect in activating its
associated signaling pathways, such as PI3-kinase in the SC
adipose tissue.
45 Additional analyses in our cohort revealed that
SCD1 mRNA and protein levels are highly and signiﬁcantly
associated in the SC depot (r¼0.85, Po0.01), whereas this
correlation was absent in the OM depot. This result indirectly
suggests the predominance of transcriptional regulation of SCD1
in the SC depot. In the OM depot, an alternative post-
transcriptional mechanism might take place. To date, only
polyunsaturated fatty acids have been shown to impair SCD1
mRNA stability in adipocytes.
46 This may account for the depot-
speciﬁc difference observed in our study.
Taken together, and in agreement with other studies,
15,16,47 our
observations suggest that enhanced fat storage in the insulin-
sensitive SC depot is associated with increased SCD1 transcription
and activity. We speculate that this may be associated with the
insulin sensitivity levels in our patients, who have relatively minor
metabolic alterations.
Limitations of the study should be taken into consideration. The
cross-sectional nature of the design prevents us to establish
cause-and-effect relationships. The use of a food frequency
questionnaire can also be seen as a limitation. However, as the
fatty acid intake was generally well represented in adipose tissue,
we suggest that the questionnaire was representative, at least for
lipid composition. Further studies are needed with a larger pool of
subjects as well as male participants.
In conclusion, our study demonstrates that in women, the
presence of large adipocytes and increased adipose mass in a
given fat compartment is related to reduced 18:0 content and
increased fatty acid desaturation. This is also associated with an
altered fat depot distribution in SCD1 and IR expression, as well as
ERK1/2 expression and activation. These alterations are indepen-
dent of dietary fat intake and suggest that SCD1-mediated
desaturation in SC adipose tissue may exert a protective effect
from metabolic disorders.
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